New hope for patients with less common breast cancer
WASHINGTON - A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't seen major drug advances in over a decade, researchers reported recently.
Results from the study, presented at the annual meeting of the American Society for Clinical Oncology, are expected to be submitted to regulators and could soon establish a new first-line therapy for people with HER2-positive metastatic breast cancer -- the advanced stage of a form that comprises 15-20 per cent of all breast cancer cases. Patients with HER2-positive breast cancer that has spread to other parts of the body live around five years. - 123RF file photo
HER2-positive cancers are fueled by an overactive HER2 gene, which makes too much of a protein called human epidermal growth factor receptor 2 that helps cancer cells grow and spread.
Patients with HER2-positive breast cancer that has spread to other parts of the body live around five years.
"Seeing such a striking improvement was really impressive to us -- we were taking a standard and almost doubling how long patients could have their cancer controlled for," oncologist Sara Tolaney, chief of the breast oncology division at Dana-Farber Cancer Institute, told AFP.
The current standard of care, known as THP, combines chemotherapy with two antibodies that block growth signals from the HER2 protein. The new approach uses a drug called trastuzumab deruxtecan (T-DXd), an antibody attached to a chemotherapy drug.
'Smart bomb'
This "smart bomb" strategy allows the drug to target cancer cells directly. "You can bind to the cancer cell and dump all that chemo right into the cancer cells," explained Tolaney.
"Some people call them smart bombs because they're delivering chemo in a targeted fashion -- which is how I think we're able to really increase efficacy so much."
Common side effects included nausea, diarrhea and a low white blood cell count, with a less common effect involving lung scarring.
T-DXd is already approved as a "second-line" option -- used when first-line treatments stop working. But in the new trial, it was given earlier, paired with another antibody, pertuzumab.
In a global trial led by Tolaney, just under 400 patients were randomly assigned to receive T-DXd in combination with pertuzumab, thought to enhance its effects.
A similar number received the standard THP regimen. A third group, who received T-DXd without pertuzumab, was also enrolled -- but those results haven't yet been reported.
44 per cent risk reduction
At a follow-up of 2.5 years, the T-DXd and pertuzumab combination reduced the risk of disease progression or death by 44 per cent compared to standard care.
Fifteen per cent of patients in the T-DXd group saw their cancer disappear entirely, compared to 8.5 per cent in the THP group.
Because this was an interim analysis, the median progression-free survival -- meaning the point at which half the patients had seen their cancer return or worsen -- was 40.7 months with the new treatment, compared to 26.9 months with the standard, and could rise further as more data come in.
Tolaney said the results would be submitted to regulators around the world, including the US Food and Drug Administration, and that future work would focus on optimising how long patients remain on the treatment, particularly those showing complete remission.
"This represents a new first-line standard treatment option for HER2-positive metastatic breast cancer," said Dr. Rebecca Dent, a breast cancer specialist at the National Cancer Center Singapore who was not involved in the study. - AFP
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sinar Daily
a day ago
- Sinar Daily
New T-Rex ancestor discovered in drawers of Mongolian institute
The fossils were first dug up in southeastern Mongolia in the early 1970s but at the time were identified as belonging to a different tyrannosaur, Alectrosaurus. 21 Jun 2025 06:00pm This handout artist's illustration made available by University of Calgary on June 6, 2025, shows the newly discovered dinosaur species Khankhuuluu mongoliensis, an ancestor of Tyrannosaurus Rex. Misidentified bones that languished in the drawers of a Mongolian institute for 50 years belong to a new species of tyrannosaur that rewrites the family history of the mighty T-Rex, scientists said on June 11, 2025. (Photo by Julius CSOTONYI / University of Calgary / AFP) PARIS - Misidentified bones that languished in the drawers of a Mongolian institute for 50 years belong to a new species of tyrannosaur that rewrites the family history of the mighty T-Rex, scientists said Wednesday. This slender ancestor of the massive Tyrannosaurus Rex was around four metres (13 feet) long and weighed three quarters of a tonne, according to a new study in the journal Nature. "It would have been the size of a very large horse," study co-author Darla Zelenitsky of Canada's University of Calgary told AFP. The fossils were first dug up in southeastern Mongolia in the early 1970s but at the time were identified as belonging to a different tyrannosaur, Alectrosaurus. For half a century, the fossils sat in the drawers at the Institute of Paleontology of the Mongolian Academy of Sciences in the capital Ulaanbaatar. Then PhD student Jared Voris, who was on a trip to Mongolia, started looking through the drawers and noticed something was wrong, Zelenitsky said. It turned out the fossils were well-preserved, partial skeletons of two different individuals of a completely new species. "It is quite possible that discoveries like this are sitting in other museums that just have not been recognised," Zelenitsky added. 'Messy' family history They named the new species Khankhuuluu mongoliensis, which roughly means the dragon prince of Mongolia because it is smaller than the "king" T-Rex. Zelenitsky said the discovery "helped us clarify a lot about the family history of the tyrannosaur group because it was really messy previously". The T-Rex represented the end of the family line. It was the apex predator in North America until 66 million years ago, when an asteroid bigger than Mount Everest slammed into the Gulf of Mexico. Three quarters of life on Earth was wiped out, including all the dinosaurs that did not evolve into birds. Around 20 million years earlier, Khankhuuluu -- or another closely related family member -- is now believed to have migrated from Asia to North America using the land bridge that once connected Siberia and Alaska. This led to tyrannosaurs evolving across North America. Then one of these species is thought to have crossed back over to Asia, where two tyrannosaur subgroups emerged. One was much smaller, weighing under a tonne, and was nicknamed Pinocchio rex for its long snout. The other subgroup was huge and included behemoths like the Tarbosaurus, which was only a little smaller than the T-rex. One of the gigantic dinosaurs then left Asia again for North America, eventually giving rise to the T-Rex, which dominated for just two million years -- until the asteroid struck. - AFP
Sinar Daily
4 days ago
- Sinar Daily
Argentine nurse gets life sentence for murder of five babies
The trial also brought charges against 10 other defendants including former provincial officials and health professionals for cover-up and dereliction of duty. 19 Jun 2025 04:55pm Photo for illustration purpose only. - 123RF photo BUENOS AIRES - A nurse was sentenced to life in prison for killing five babies and attempting to murder eight others at a hospital in Argentina, according to local media. Brenda Cecilia Aguero injected potassium and insulin into newborns between March and June 2022, taking doses from emergency medical carts without inventory control, prosecutors said. Under Argentine law, Aguero will not be eligible for parole before serving 35 years. The court clerk read out the sentencing in footage broadcast on local media on Wednesday. The babies, all born healthy, died under initially unexplained circumstances at the neonatal ward of the maternal and child hospital in Cordoba province, 370 miles (600 km) northwest of Buenos Aires. Eight others survived due to swift medical intervention. The trial also brought charges against 10 other defendants including former provincial officials and health professionals for cover-up and dereliction of duty. Those charged included a former health minister and secretary of health of Cordoba province, as well as the former hospital director. Aguero, who was arrested in 2022, denied the charges, earlier telling the court "they have no evidence" and accusing media of portraying her as a "serial killer." Of the other defendants, five were found guilty but received lesser sentences while five others were acquitted, including the former provincial officials, according to local outlet Infobae. - AFP More Like This
Sinar Daily
4 days ago
- Sinar Daily
Singapore confirms two Zika cases in Woodlands
The NEA advised residents in the area, especially pregnant women, to protect themselves from mosquito bites and to monitor their health closely. 19 Jun 2025 02:06pm Photo for illustration purpose only. - 123RF photo SINGAPORE - Singapore's National Environment Agency (NEA) and the Communicable Diseases Agency (CDA) on Thursday confirmed two local Zika cases at Woodlands Street 11 and Street 32. In a Facebook post, the NEA said it has commenced wastewater and mosquito surveillance in the surrounding residential areas following each case notification. The NEA advised residents in the area, especially pregnant women, to protect themselves from mosquito bites and to monitor their health closely. - Photo illustrated via Canva "This enhanced surveillance has revealed persistent Zika virus signals in the area, which suggests that this is an area with likely Zika transmission,' it said. The NEA advised residents in the area, especially pregnant women, to protect themselves from mosquito bites and to monitor their health closely. "Persons showing symptoms suggestive of Zika infections should see a doctor early, to be diagnosed and managed accordingly,' the NEA added. Zika virus infection is a mosquito-borne disease caused by the Zika virus. It is transmitted through the bite of an infected Aedes mosquito. In a separate post, the CDA said symptoms of Zika include rashes, fever, joint pain, muscle pain, headache, and conjunctivitis (red eye). Infection during pregnancy can cause certain birth defects in the foetus, including neurological complications and microcephaly, where the baby's head is much smaller than expected, the CDA said on its website. - BERNAMA
